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Abstract
Background: Acute kidney injury (AKI) is associated with increased short-term mortality of septic patients; however, 
the exact influence of AKI on long-term mortality in such patients has not yet been determined.
Methods: We retrospectively evaluated the impact of AKI, defined by the "Risk, Injury, Failure, Loss of kidney function, 
End-stage kidney disease" (RIFLE) classification based on creatinine criteria, on 2-year mortality in a cohort of 234 
hospital surviving septic patients who had been hospitalized at the Infectious Disease Intensive Care Unit of our 
Hospital.
Results: Mean-follow-up was 21 ± 6.4 months. During this period, 32 patients (13.7%) died. At 6 months, 1 and 2 years 
of follow-up, the cumulative probability of death of patients with previous AKI was 8.3, 16.9 and 34.2%, respectively, as 
compared with 2.2, 6 and 8.9% in patients without previous AKI (log-rank, P < 0.0001). In the univariate analysis, age 
(hazard ratio 1.4, 95% CI 1.2-1.7, P < 0.0001), as well as pre-existing cardiovascular disease (hazard ratio 3.6, 95% CI 1.4-
9.4, P = 0.009), illness severity as evaluated by nonrenal APACHE II (hazard ratio 1.3, 95% CI 1.1-1.6, P = 0.002), and 
previous AKI (hazard ratio 4.2, 95% CI 2.1-8.5, P < 0.0001) were associated with increased 2-year mortality, while gender, 
race, pre-existing hypertension, cirrhosis, HIV infection, neoplasm, and baseline glomerular filtration rate did not. In the 
multivariate analysis, however, only previous AKI (hazard ratio 3.2, 95% CI 1.6-6.5, P = 0.001) and age (hazard ratio 1.4, 
95% CI 1.2-1.6, P < 0.0001) emerged as independent predictors of 2-year mortality.
Conclusions: Acute kidney injury had a negative impact on long-term mortality of patients with sepsis.
Background
Acute kidney injury (AKI) is a common complication
among hospitalized patients, particularly in the Intensive
Care Unit (ICU) setting, and it portends an ominous out-
come. In fact, the incidence of AKI in critically ill patients
varies from 35 to 70%, and it is associated with increased
in-hospital mortality (10 to 60%) [1-4].
Although AKI is a common complication in the hospi-
tal and has an immediate impact on morbidity, mortality,
and resource utilization, its detrimental effect appears to
persist also after recovery, since AKI has shown to
increase long-term mortality [5-7]. Understanding the
impact of AKI on long-term outcomes will have a marked
impact on treatment and risk stratification during hospi-
talization and will assist with guiding follow-up care after
discharge.
Sepsis is a well-known risk factor for the development
of AKI and nearly half of all patients with AKI have sepsis
[8,9]. Furthermore, AKI is associated with increased
short-term mortality among septic patients [8-14].
Despite the detrimental effect of AKI on short-term out-
come, to our knowledge, there is no study evaluating the
influence of AKI on long-term mortality of hospital sur-
viving septic patients.
In the present study, we sought to evaluate the impact
of AKI on long-term mortality in a cohort of patients
with sepsis.
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Methods
This is a retrospective study that evaluated the influence
of AKI during previous ICU admission on long-term
mortality of hospital surviving septic patients admitted to
the Infectious Disease Intensive Care Unit of our hospital
between July 2002 and June 2007. This unit is the refer-
ence medical infectious disease unit for adult patients
with infectious diseases who need intensive care, provid-
ing medical assistance to an area (Lisbon to south of Por-
tugal) with almost 3000000 inhabitants.
Since this was a retrospective and observational study
that did not evaluate a specific therapeutic or prophylac-
tic intervention the institutional ethical approval was not
required according to our institution's guidelines.
Selection criteria, population and study periods
Between July 2002 and June 2007, 454 patients with sepsis
were admitted to the unit; 28 of them were chronic kid-
ney disease patients on dialysis and were not included in
t h i s  s t u d y .  N o n e  o f  t h e  p a t i e n t s  h a d  r e c e i v e d  a  r e n a l
transplant. From the 426 remaining patients (mean age:
53.3 years, 281 male, 379 Caucasian, mean APACHE II
score: 21.3) (Table 1), 122 of them died within hospital-
ization and, therefore, 304 patients were discharged alive
from the hospital (Table 2 and Table 3). Mortality was
assessed at 2-years of follow-up. For those patients who
were followed-up at the hospital with a documented
medical visit at or after 2 years after hospital discharge,
and for those patients who died at the hospital during a
subsequent hospitalization after hospital discharge, long-
term outcome was assessed based on hospital records.
On the other hand, for those patients who were not fol-
lowed-up at the hospital, the long-term outcome was
assessed by phone call to patients or their family by using
contact details provided on hospital database. We could
not analyze the long-term outcome of 70 patients who
were lost to follow-up. Therefore, in this study, we
focused on 234 patients with sepsis, and analyzed their
mortality at 2 years of follow-up as a cohort.
Definitions
Acute kidney injury was defined and categorized accord-
ing to "Risk Injury Failure Loss of kidney function End-
stage kidney disease" (RIFLE) classification, based on cre-
atinine criteria [15]. Acute kidney injury was defined as
an increase of baseline serum creatinine × 1.5, and in
patients with baseline serum creatinine > 4 mg/dl it was
also considered if there was an acute rise in serum creati-
nine of at least 0.5 mg/dl; Class R (Risk) was considered if
there was an increase of baseline serum creatinine × 1.5;
class I (Injury) was considered if there was an increase of
baseline serum creatinine × 2; and Class F (Failure) was
considered if there was an increase of baseline serum cre-
atinine × 3, or in patients with baseline serum creatinine
> 4 mg/dl if there was an acute rise in serum creatinine of
at least 0.5 mg/dl. When pre-admission serum creatinine
was available it was considered the baseline serum creati-
nine, and when it was unavailable baseline serum creati-
nine was estimated by the Modification of Diet in Renal
Disease equation [16], as recommended (assuming a
lower limit of the normal baseline glomerular filtration
rate of 75 ml/min/1.73 m2) and previously applied [1,15].
In this unit, serum creatinine is determined at least once
a day.
Sepsis was classified in accordance with the American
College of Chest Physicians and the Society of Critical
Care Medicine consensus [17] and Acute Physiology and
Chronic Health Evaluation, version II (APACHE II) score
was used to evaluate illness severity, and was calculated
based on the worst variables recorded during the first 24
hours of ICU admission [18].
Complete renal function recovery was considered if the
serum creatinine at hospital discharge with reference to
baseline serum creatinine was lower than × 1.5, and in
patients with baseline serum creatinine > 4 mg/dl com-
plete renal function recovery was also considered if
serum creatinine at hospital discharge was also lower
than 0.5 mg/dl with reference to baseline serum creati-
nine.
Variables
Variables such as age, gender, race, comorbidity (diabetes
mellitus, hypertension, cardiovascular disease which
included chronic heart failure and coronary artery dis-
ease, cirrhosis, human immunodeficiency virus infection,
and neoplasm), APACHE II score, need for mechanical
ventilation, vasopressors use, daily serum creatinine as
well as renal replacement therapy were collected from the
unit database and patient medical charts.
Statistical analysis
Continuous variables are expressed as mean (standard
deviation) and categorical variables as percentage of
number of cases. Comparisons between patients with and
without AKI were performed using the Student's t-test
and the χ2-test, respectively, for continuous and categori-
cal variables.
Only the first ICU presentation was analyzed for
patients with multiple ICU admissions. Cumulative mor-
tality curves were determined by the Kaplan-Meier
method, and log-rank test was employed to analyze sta-
tistically significant differences between curves. Cox
regression method was used to determine independent
predictors of mortality. Risk factors were assessed with
univariate analysis, and variables that were statistically
significant (P  < 0.05) in the univariate analysis were
included in the multivariate analysis by applying a multi-
ple forward stepwise Cox regression. The nonrenal
APACHE II score was chosen as a covariate to control for
multicollinearity between the AKI and scoring system
that includes points for kidney insufficiency such as theLopes et al. BMC Nephrology 2010, 11:9
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APACHE II score. Data are presented as unadjusted and
adjusted hazard ratios (HR) with 95% confidence inter-
vals (CI). A two-tailed P value less than 0.05 was consid-
ered significant.
Analysis was performed with the statistical software
package SPSS 16.0 for Windows.
Results
Acute kidney injury
Baseline serum creatinine was available in 293 patients
(68.8%), and in the remaining cases (n = 133; 31.2%) it
was estimated by the Modification of Diet in Renal Dis-
e a s e  e q u a t i o n .  A c u t e  k i d n e y  i n j u r y  o c c u r r e d  i n  1 3 8
patients (32.4%), as follows: 26 patients (6.1%) were on
class R, 34 patients (8%) were on class I, and 78 patients
(18.3%) were on class F. Mean time to AKI development
was 2.9 (4.7) days (1-19 days). As expected, patients with
AKI were older, were more likely to have pre-existing car-
diovascular disease, and had more severe disease as eval-
uated by total APACHE II score and nonrenal APACHE
II score. Furthermore, baseline creatinine values were
higher among patients with AKI, and septic shock and
Table 1: Baseline characteristics of the overall cohort of septic patients.
Variable Without AKI1 (n = 288) With AKI (n = 138) P
Mean age (years) 50.7 (18.3) 58.8 (16.4) < 0.0001
Male (%) 62.8 72.5 0.064
Caucasian (%) 90.6 85.5 0.158
DM2 (%) 14.6 16.7 0.678
Hypertension (%) 20.5 23.9 0.497
CVD3 (%) 6.6 20.3 < 0.0001
Cirrhosis (%) 11.8 10.1 0.731
HIV infection4 (%) 16.3 17.4 0.890
Neoplasm (%) 6.2 11.6 0.087
APACHE II score5 18.3 (8) 27.5 (8.6) < 0.0001
Nonrenal APACHE II score6 17.7 (7.8) 23.9 (8.6) < 0.0001
Baseline SCr (mg/dL)7 0.8 (0.2) 1 (0.5) < 0.0001
Septic shock (%) 22.6 60.1 < 0.0001
MV8 (%) 39.2 59.4 < 0.0001
Length of hospital stay (days) 10.7 (12.5) 12 (13.6) 0.328
In-hospital mortality (%) 15.6 55.8 < 0.0001
1AKI-acute kidney injury. 2DM-diabetes mellitus. 3CVD-cardiovascular disease includes chronic heart failure and coronary artery disease. 4HIV 
infection-human immunodeficiency virus infection. 5APACHE II score-acute physiology and chronic health evaluation, version II score. 
6Nonrenal APACHE II score-acute physiology and chronic health evaluation, version II score not including points for kidney insufficiency. 
7Baseline SCr-baseline serum creatinine. 8MV-need for mechanical ventilation.Lopes et al. BMC Nephrology 2010, 11:9
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need for mechanical ventilation were more frequent in
such patients (Table 1 and Table 2). Forty-one AKI
patients (29.7%) did undergo renal replacement therapy
(continuous venovenous hemodiafiltration in 23 patients,
intermittent hemodialysis in 13 patients, and 5 patients
were treated with both modalities). Patients with AKI had
a greater risk for death within hospitalization (Table 1).
Regarding hospital survivors lost to follow-up and with
known follow-up it should be mentioned that they were
similar in terms of age, gender, race, medical history, ill-
ness severity, baseline renal function, proportion of
patients with AKI, proportion of AKI patients in the dif-
ferent RIFLE categories or undergoing renal replacement
therapy, percentage of patients with septic shock or need
for mechanical ventilation, and length of hospitalization
(Table 3). The characteristics of the surviving and non
surviving patients with AKI during ICU admission are
described in Table 4.
Long-term outcome
In this study, we focused on 234 patients [mean age: 51.2
(18.2) years, 149 male, 210 Caucasian, mean APACHE II
score: 18.3 (8.2)] with sepsis, and analyzed their mortality
at 2 years of follow-up as a cohort. Mean-follow-up was
21 (6.4) months. During this period, 32 patients (13.7%)
died. The probability of death significantly differed
among patients with AKI and without AKI during previ-
Table 2: Baseline characteristics of the hospital surviving septic patients.
Variable Without AKI1 (n = 243) With AKI (n = 61) P
Mean age (years) 50.2 (18.2) 58.8 (16.3) 0.001
Male (%) 60.5 77 0.024
Caucasian (%) 90.5 83.6 0.185
DM2 (%) 15.2 22.9 0.211
Hypertension (%) 21.8 32.8 0.104
CVD3 (%) 4.1 13.1 0.018
Cirrhosis (%) 11.1 9.8 0.955
HIV infection4 (%) 12.3 13.1 0.957
Neoplasm (%) 5.3 13.1 0.063
APACHE II score5 16.9 (7.5) 24.2 (7.4) < 0.0001
Nonrenal APACHE II score6 16.3 (7.2) 20.5 (7.5) < 0.0001
Baseline SCr (mg/dL)7 0.8 (0.2) 1.1 (0.4) < 0.0001
Septic shock (%) 18.1 55.7 < 0.0001
MV8 (%) 32.5 47.5 0.041
Length of hospital stay (days) 10.7 (13) 12.8 (9.2) 0.233
1AKI-acute kidney injury. 2DM-diabetes mellitus. 3CVD-cardiovascular disease includes chronic heart failure and coronary artery disease. 4HIV 
infection-human immunodeficiency virus infection. 5APACHE II score-acute physiology and chronic health evaluation, version II score. 
6Nonrenal APACHE II score-acute physiology and chronic health evaluation, version II score not including points for kidney insufficiency. 
7Baseline SCr-baseline serum creatinine. 8MV-need for mechanical ventilation.Lopes et al. BMC Nephrology 2010, 11:9
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Table 3: Baseline characteristics of the hospital surviving septic patients with known or unknown follow-up.
Variable Known follow-up (n = 234) Unknown follow-up (n = 70) P
Mean age (years) 51.2 (18.2) 54.2 (17.9) 0.234
Male (%) 63.7 64.3 0.961
Caucasian (%) 89.7 87.1 0.693
DM1 (%) 15.8 20 0.522
Hypertension (%) 24.3 22.9 0.921
CVD2 (%) 6 5.7 0.838
Cirrhosis (%) 10.7 11.4 0.258
HIV infection3 (%) 13.7 8.6 0.354
Neoplasm (%) 1 0 0.371
APACHE II score4 18.3 (8.2) 18.7 (7.2) 0.751
Nonrenal APACHE II score5 17 (7.6) 17.5 (6.9) 0.644
Baseline SCr (mg/dL)6 0.8 (0.3) 0.8 (0.3) 0.922
Septic shock (%) 24.8 28.6 0.631
MV7 (%) 35 37.1 0.857
AKI8 (%) 20.5 18.6 0.853
Class R (%) 5.5 1.4 0.270
Class I (%) 6.8 6 0.410
Class F (%) 8.9 8.6 0.873
RRT9 (%) 29.2 15.4 0.518
Complete RFR10 (%) 87.5 100 0.414
Length of hospital stay (days) 10.9 (11.2) 11.8 (15.7) 0.589
1DM-diabetes mellitus. 2CVD-cardiovascular disease includes chronic heart failure and coronary artery disease. 3HIV infection-human 
immunodeficiency virus infection. 4APACHE II score-acute physiology and chronic health evaluation, version II score. 5Nonrenal APACHE II 
score-acute physiology and chronic health evaluation, version II score not including points for kidney insufficiency. 6Baseline SCr-baseline 
serum creatinine. 7MV-need for mechanical ventilation. 8AKI-acute kidney injury. 9RRT-need for renal replacement therapy. 10RFR-renal 
function recovery.Lopes et al. BMC Nephrology 2010, 11:9
http://www.biomedcentral.com/1471-2369/11/9
Page 6 of 10
ous ICU admission (Figure 1). At 6 months, 1 and 2 years
of follow-up, the cumulative probability of death of
patients with AKI was 8.3, 16.9 and 34.2%, respectively, as
compared with 2.2, 6 and 8.9% in patients without AKI
(log-rank, P < 0.0001) (Figure 1). When we analyzed 2-
year mortality in the different RIFLE categories, however,
we did not find any statistically significant difference
(class R, 7.7%; class I, 50%; class F, 38.1%; P = 0.055). In
the univariate analysis, age (HR 1.4, 95% CI 1.2-1.7, P <
0.0001), as well as preexisting cardiovascular disease (HR
3.6, 95% CI 1.4-9.4, P = 0.009), illness severity as evalu-
ated by nonrenal APACHE II (HR 1.3, 95% CI 1.1-1.6, P =
0.002), and AKI during previous ICU admission (HR 4.2,
95% CI 2.1-8.5, P  < 0.0001) were associated with
increased 2-year mortality, while gender, race, pre-exist-
ing hypertension, cirrhosis, HIV infection, neoplasm, and
baseline glomerular filtration rate did not. In the multi-
variate analysis, however, only AKI during previous ICU
admission (AHR 3.2, 95% CI 1.6-6.5, P = 0.001) and age
(AHR 1.4, 95% CI 1.2-1.6, P < 0.0001) emerged as inde-
pendent predictors of 2-year mortality (Table 5).
Of interest, 2-year mortality did not significantly differ
between AKI patients who completely recovered renal
function (n = 14, 33.3%) and those who did not (n = 2,
33.3%).
Table 4: Baseline characteristics of hospital surviving and non surviving patients with acute kidney injury during 
Intensive Care Unit admission.
Variable Non survivors (n = 77) Survivors (n = 61) P
Mean age (years) 58.8 (16.6) 58.8 (16.3) 0.991
Male (%) 68.8 77 0.378
Caucasian (%) 87 83.6 0.748
DM1 (%) 11.7 22.9 0.125
Hypertension (%) 16.9 32.8 0.048
CVD2 (%) 25.9 13.1 0.098
Cirrhosis (%) 10.4 9.8 0.885
HIV infection3 (%) 20.8 13.1 0.340
Neoplasm (%) 10.4 13.1 0.819
APACHE II score4 30 (8.6) 24.2 (7.4) < 0.0001
Nonrenal APACHE II score5 26.7 (8.5) 20.5 (7.5) < 0.0001
Baseline SCr (mg/dL)6 1 (0.5) 1 (0.4) 0.379
Septic shock (%) 63.6 55.7 0.444
MV7 (%) 68.8 47.5 0.019
RRT8 (%) 32.5 26.2 0.543
1DM-diabetes mellitus. 2CVD-cardiovascular disease includes chronic heart failure and coronary artery disease. 3HIV infection-human 
immunodeficiency virus infection. 4APACHE II score-acute physiology and chronic health evaluation, version II score. 5Nonrenal APACHE II 
score-acute physiology and chronic health evaluation, version II score not including points for kidney insufficiency. 6Baseline SCr-baseline 
serum creatinine. 7MV-need for mechanical ventilation. 8RRT-need for renal replacement therapy.Lopes et al. BMC Nephrology 2010, 11:9
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Page 7 of 10
Discussion
It has been shown that patients who survive AKI have a
greater rate of long-term mortality and other adverse out-
comes than patients who survive hospitalization without
AKI, in varied settings, such as community/hospitalized
patients, hospitalized patients, ICU patients, cardiac sur-
gery, patients undergoing aortic stent placement or per-
cutaneous coronary intervention, liver transplant and
lung transplant [19].
Sepsis is a well-known risk factor for the development
of AKI and nearly half of all patients with AKI have sepsis
[ 8 , 9 ] .  F u r t h e r m o r e ,  A K I  i s  a s s o c i a t e d  w i t h  s h o r t - t e r m
mortality among septic patients [8-14]. Despite the detri-
mental effect of AKI on short-term outcome, to our
knowledge, the influence of AKI on long-term mortality
of septic patients has not yet been assessed.
We conducted a retrospective study of a cohort of 234
hospital surviving septic patients, in order to determine
the impact of AKI during ICU admission on 2-year mor-
tality. We found that AKI had a negative impact on 2-year
mortality of patients with sepsis. As compared with
patients without acute renal impairment, patients with
AKI had an increased probability of death of 25.3%,
which corresponded to a 3.2-fold risk of death. These
findings expand on results from previous studies that
showed the increased risk of short-term death associated
with AKI in septic patients [8-14].
The mechanism by which AKI contributes to decreased
long-term survival is not completely understood. After an
Figure 1 Cumulative probability of death. Cumulative probability of death in patients with (green line) and without (blue line) acute kidney injury 
(AKI) during previous Intensive Care Unit admission; log-rank test, P < 0.0001.Lopes et al. BMC Nephrology 2010, 11:9
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episode of AKI, it is likely that there is failure to resolve
renal structure and function adequately [20-22]. Acute
kidney injury itself may increase the risk of subsequent
events and decrease kidney reserve leading to an
increased risk of chronic kidney disease. In fact, despite
we do not have serial values of blood pressure, serum cre-
atinine and proteinuria, it has been shown that chronic
kidney disease with subsequent hypertension, proteinuria
and increased cardiovascular disease has been appointed
as a possible cause of poor long-term outcome among
AKI patients [23]. Moreover, volume overload, coagula-
tion abnormalities, an increased incidence of sepsis with
multi-organ failure, and cytokine or immune-mediated
major organ dysfunction are other possible explanations
for poor survival among AKI patients [24,25].
In the present study, mortality did not differ among
AKI patients with and without complete renal function
recovery. These results should be interpreted with
extreme caution, since the number of patients may be
insufficient to detect a difference on outcome. However,
the similar outcome between AKI patients who did or not
recover renal function could also be explained by the per-
manent injury to other vital organs caused by AKI, thus
affecting future survival, despite the reversible nature of
clinical AKI in which serum creatinine level returns to
baseline after the episode [24-26]. Therefore, our results
could also suggest that despite patients with septic AKI
are prone to recover renal function [9,14], they should be
closely monitored after discharge.
Our study has several limitations. First, the single-cen-
tre nature of the study largely limits its generalizability,
and its retrospective design with a relatively small cohort
of patients did not allow the evaluation of other con-
founders with prognostic importance. Second, baseline
serum creatinine was available only in 68.8% of patients,
while in the remaining cases (31.2%) it was estimated by
the Modification of Diet in Renal Disease equation, as it
has been recommended and previously applied [1,15].
Regarding this, it should be stressed that the use of Modi-
fication of Diet in Renal Disease equation to estimate
Table 5: Univariate and multivariate Cox regression analysis to determine predictors of 2-year mortality.
Variable Unadjusted HR1 (95% CI3) P AHR2 (95% CI3) P
Age (per 10 years) 1.4 (1.2-1.7) < 0.0001 1.4 (1.2-1.6) < 0.0001
Gender (male) 1.1 (0.5-2.3) 0.752
Race (Caucasian) 3.8 (0.5-27.6) 0.192
Diabetes mellitus 2.1 (0.9-4.6) 0.06
Hypertension 1.7 (0.8-3.4) 0.177
CVD4 3.6 (1.4-9.4) 0.009
Cirrhosis 0.9 (0.3-2.8) 0.813
HIV infection5 1.9 (0.9-4.6) 0.107
Neoplasm (%) 2.5 (0.9-7.1) 0.088
Baseline GFR6 (per 10 ml/min/1.73 m2) 1.1 (0.9-1.3) 0.063
Nonrenal APACHE II7(per 5 points) 1.3 (1.1-1.6) 0.002
AKI8 4.2 (2.1-8.5) < 0.0001 3.2 (1.6-6.5) 0.001
1HR-hazard ratios. 2AHR-adjusted hazard ratios. 3CI-confidence intervals. 4CVD-Cardiovascular disease includes chronic heart failure and 
coronary artery disease. 5HIV infection-human immunodeficiency virus infection. 6GFR-baseline glomerular filtration rate. 7Nonrenal APACHE 
II score-acute physiology and chronic health evaluation, version II score not including points for kidney insufficiency. 8AKI-acute kidney injury 
during previous ICU admission.Lopes et al. BMC Nephrology 2010, 11:9
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baseline serum creatinine, despite performing reasonable
well when basal glomerular filtration rate is normal or
near normal, could overestimate the incidence of AKI in
chronic kidney disease patients [27]. Third, the evolution
for chronic kidney disease and end-stage renal disease
after AKI, as well as the causes of death were unattain-
able. Fourth, outcome data were available only in 77% of
patients. Regarding this issue, it is important to mention
that hospital survivors lost to follow-up and with known
follow-up were similar in terms of age, gender, race, med-
ical history, illness severity, baseline renal function, pro-
portion of patients with AKI, proportion of AKI patients
in the different RIFLE categories or undergoing renal
replacement therapy, percentage of patients with septic
shock or need for mechanical ventilation, and length of
hospitalization. Taking into consideration the similar
characteristics of hospital survivors lost to follow-up and
with known follow-up, we think that it is not expectable
that substantially different results would be achieved if
the outcome data of all surviving patients was available.
In fact, our results are in line with those focusing on the
effect of AKI on long-term outcome in other settings
[19], and likely, AKI can also exert a negative influence on
long-term outcome of patients with sepsis. Finally, the
number of patients in the different AKI categories was
too small to determine the role of severity of AKI on
long-term outcome.
Despite the aforementioned constraints, our study has
the main virtue of being, to our knowledge, the first study
reporting the negative impact of AKI on long-term mor-
tality of patients with sepsis, a specific setting where AKI
is pathophysiological and clinically distinct from AKI of
other etiologies [9,28]. The appropriate management of
the patients with sepsis through early goal-directed
resuscitation, early administration of broad-spectrum
antibiotic therapy, therapy with vasopressor agents (when
fluid challenge fails to restore adequate blood pressure
and organ perfusion), use of recombinant activated pro-
tein C (in patients with severe sepsis and high risk for
death), use of low-tidal volume ventilation and blood glu-
cose control is essential to prevent or limit AKI severity
and, as such, could improve the long-term outcome of
septic patients after hospital discharge [29].
Conclusions
Our results suggest that AKI negatively influences long-
term mortality of patients with sepsis. Despite septic
patients who develop AKI and survive their acute episode
have greater likelihood for renal function recovery the
negative impact of AKI on long-term mortality deserves
an additional effort to closely monitor them after hospital
discharge.
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